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Long bone abnormality (lbab/lbab) is a strain of dwarf mice. Recent studies revealed that the 
phenotype is caused by a spontaneous mutation in the Nppc gene, which encodes mouse C-type 
natriuretic peptide (CNP). In this study, we analyzed the chondrodysplastic skeletal phenotype of 
lbab/lbab mice. At birth, lbab/lbab mice are only slightly shorter than their wild-type littermates. 
Nevertheless, lbab/lbab mice do not undergo a growth spurt, and their final body and bone lengths are 
only ~60% of those of wild-type mice. Histological analysis revealed that the thickness of the growth 
plate in lbab/lbab mice, especially that of the hypertrophic chondrocyte layer, was significantly 
thinner than in wild-type mice. Overexpression of CNP in the cartilage of lbab/lbab mice restored 
their thinned growth plate, followed by the complete rescue of their impaired endochondral bone 
growth. Furthermore, the bone volume in lbab/lbab mouse was severely decreased, and was recovered 
by CNP overexpression. On the other hand, the thickness of the growth plate of lbab/+ mice was not 
different from that of wild-type mice; accordingly, impaired endochondral bone growth was not 
observed in lbab/+ mice. In organ culture experiments, tibial explants from fetal lbab/lbab mice were 
significantly shorter than those from lbab/+ mice, and were elongated by addition of 107 M CNP to 
the same extent as lbab/+ tibiae treated with the same dose of CNP. These results demonstrate that 
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C-type natriuretic peptide (CNP) is a member of the natriuretic peptide family, and exerts its 
biological actions through the accumulation of intracellular cyclic GMP via a subtype of membranous 
guanylyl cyclase receptor, guanylyl cyclase-B (GC-B) [1, 2]. We had previously demonstrated that the 
CNP/GC-B system is a potent stimulator of endochondral bone growth: transgenic mice with targeted 
overexpression of CNP in cartilage under the control of type II collagen promoter [3], or those with 
elevated plasma CNP concentrations under the control of human serum amyloid P component 
promoter [4], exhibit a prominent skeletal overgrowth phenotype. On the other hand, the physiological 
importance of the CNP/GC-B system on endochondral bone growth has been revealed by the 
phenotypes of hypomorphs. We generated complete CNP or GC-B null mice, and demonstrated that 
they exhibit an impaired bone growth phenotype [5, 6]. We have also reported that two lines of 
spontaneous mutant mice with disproportionate dwarfism, cn/cn and slw/slw, are caused by 
loss-of-function mutations in the murine GC-B gene [7, 8]. The skeletal phenotypes of these mutant 
mice resemble those of GC-B knockout mice. Furthermore, recent studies have elucidated that 
loss-of-function mutations in the human GC-B gene are the causes of acromesomelic dysplasia type 
Maroteaux (AMDM), one form of skeletal dysplasias with disproportionate short stature phenotype [9]. 
The impaired skeletal growth phenotype observed in patients suffering from AMDM is similar to the 
skeletal phenotype of cn/cn, slw/slw, or GC-B knockout mice. 
The long bone abnormality (lbab/lbab) mouse was first identified in The Jackson Laboratory 
as a spontaneous autosomal recessive mutant mouse characterized by impaired growth of long bones 
[10]. Recent studies have elucidated that the impaired growth of lbab/lbab mouse is caused by a 
hypomorphic mutation in the mouse CNP gene; Jiao et al. found that its impaired growth phenotype is 
associated with a single point mutation in the mouse CNP gene [11], and we showed that this 
phenotype is completely recovered by CNP overexpression [12]. Yoder et al. characterized the mutant 
CNP in lbab/lbab mouse, and exhibited that it is less biologically active than authentic CNP; in whole 
cell cGMP elevation and membrane guanylyl cyclase assays, 30-fold to greater than 100-fold more 
mutant CNP is required to activate GC-B as compared to authentic CNP [13]. We also confirmed that 
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the mutant CNP in lbab/lbab mouse retains only about 10 % activity to induce cyclic GMP production 
through GC-B compared to authentic CNP in in vitro transfection assay using COS-7 cells [12]. 
Collectively, lbab/lbab mouse is a novel chondrodysplastic mouse model with insufficient CNP action 
on endochondral bone growth. Nevertheless, the skeletal phenotypes of lbab/lbab mouse have only 
been partially described in short reports including our own brief communication [11-13], and have not 
yet been fully studied. In this study, we performed further analyses of the skeletal phenotypes of 
lbab/lbab mouse. 
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Materials and Methods 
 
Mice 
Heterozygous (Lbab/+) mice (C57BL/6J background) were obtained from The Jackson Laboratory, 
and the strain was maintained by sib mating of heterozygotes. Transgenic mice with targeted 
overexpression of CNP in the growth plate chondrocytes under the control of the mouse pro-1(II) 
(Col2a1) promoter (CNP-Tg) were created as reported previously [3]. To perform genetic rescue of 
lbab/lbab mice, CNP-Tg mice were mated with lbab/+ mice, and F1 offspring heterozygous for the 
transgene and for the Lbab allele were mated with that only for the Lbab allele to generate lbab/lbab 
mice with the transgene expression (lbab/lbabCNP-Tg/+ mice) [12]. Genotypes for the CNP 
transgene and the Lbab allele were determined by PCR analysis using mouse genomic DNAs 
extracted from tails. Because there was no tendency of gender differences in the growth of each 
genotype (data not shown), we used only female mice in our experiments. Animal care and all 
experiments were conducted in accordance with the Guidelines for Animal Experiments of Kyoto 




For 10 weeks after birth, body lengths of female mice were measured weekly. Body length was 
measured as the length from the nose to the anus (nasoanal length) or that from the nose to the tip of 
the tail (nasotail length). Body weights were also measured weekly. Skeletal analysis was performed 
as previously described [14]. Briefly, mice were subjected to soft X-ray analysis (30 kVp, 5 mA for 1 
min, Softron type SRO-M5, Softron, Tokyo, Japan), and lengths of the bones were measured on the 
X-ray films. CT scanning of the humerus was performed using a ScanXmate-L090 Scanner 
(Comscantechno Co., Ltd., Yokohama, Japan). Three-dimensional microstructural image data were 
reconstructed and structural indices were calculated using TRI/3D-BON software (RATOC System 




Tibiae were fixed in 10% formalin neutral buffer, decalcified in 10% EDTA, and embedded in paraffin. 
Five-micrometer-thick sections were sliced and stained with Alcian blue (pH 2.5) and 
hematoxylineosin. For immunohistochemistry, sections were incubated with rabbit anti-type X 
collagen antibody (LSL, Tokyo, Japan), goat anti-Indian hedgehog (Ihh) antibody (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA), mouse anti-matrix metalloproteinase 13 (MMP-13) antibody 
(Thermo Fisher Scientific Inc., MA), and mouse anti-proliferating cell nuclear antigen (PCNA) 
antibody (Dako, Copenhagen, Denmark). Immunostaining was performed using the Histofine 
MOUSESTAIN KIT (Nichirei Biosciences Inc., Tokyo, Japan) according to the manufacturer’s 
instruction. Peroxidase activity was visualized using diaminobenzidine. The sections were 
counterstained with hematoxylin, dehydrated, and then mounted with Malinol (Muto Pure Chemicals 
Co., Ltd., Tokyo, Japan). To confirm antibody specificity, normal rabbit serum (SigmaAldrich Co., 
St. Louis, MO), normal goat IgG (Santa Cruz Biotechnology Inc.), and mouse IgG (Dako) were used 
as first antibodies for negative controls, respectively. 
 
Organ culture 
Organ culture of fetal mouse tibiae or third metatarsi was performed as described previously [15]. 
Tibial or metatarsal explants from lbab/+ mice and their lbab/lbab littermates at 16.5 day post coitus 
were cultured for 4 days with vehicle or 107 M CNP (Peptide Institute, Inc., Minoh, Japan). Medium 
was changed every day. Before and after the culture, the maximal longitudinal lengths of tibiae were 
measured as the total tibial length, the sum lengths of proximal and distal cartilaginous primordia (CP), 
and the length of osteogenic center (OC), by using a linear ocular scale mounted on an inverted 
microscope. For histological analysis, explants were fixed in 10% formalin neutral buffer and 
embedded in paraffin. Five-micrometer-thick sections were sliced and stained with Alcian blue (pH 
2.5) and hematoxylineosin. Immunohistochemical staining of incorporated bromodeoxyuridine 
(BrdU) was performed using 5-Bromo-2’-deoxy-uridine Labeling and Detection Kit II (Roche Applied 
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Science) according to the manufacturer’s protocol. 
 
Statistical analysis 
Data were expressed as the mean  SEM. The statistical significance of differences between mean 




Analyses of skeletal growth of lbab/lbab and lbab/+ mice 
As previously reported, lbab/lbab mice developed severe dwarfism characterized by short tails and 
extremities [11, 12]. At birth, lbab/lbab pups were slightly shorter than their wild-type littermates: the 
naso-anal and the naso-tail lengths of lbab/lbab mice were 88% and 83% of those of their wild-type 
littermates, respectively (Fig. 1a and Supplemental Fig. 1). The ratios of nasoanal and nasotail 
lengths of lbab/lbab mice to those of wild-type mice sharply decreased to 65% and 55%, respectively, 
by the age of 3 weeks. After 5-week-old, these ratios stabilized at to 6672% and 5762%, 
respectively (Fig. 1a and Supplemental Fig. 1). The body weight of lbab/lbab mice was 68% of that of 
their wild-type littermates at birth, and was decreased to 46% by the age of 3 weeks. The ratio did not 
increase until 5 weeks of age, but was then increased and became ~60 % after 7-week-old (Fig. 1b). 
On the other hand, the lbab/+ mice were indistinguishable from their wild-type littermates at birth, 
and grew almost similarly as their wild-type littermates (Fig. 1a, b, and Supplemental Fig. 1). Soft 
X-ray analysis revealed that longitudinal growth of vertebrae, tail, and extremities was affected in 
lbab/lbab mouse at the age of 2 weeks, but not affected in lbab/+ mice (Fig. 1c). Histological analysis 
revealed that at the age of 3 days, the thickness of the tibial growth plate, especially that of the 
hypertrophic chondrocyte layer, of lbab/lbab mice was apparently thinner than that of wild-type mice 
(Fig. 1d). On the other hand, the thickness of tibial growth plate of lbab/+ mice was not different from 
that of wild-type mice (Fig. 1d). 
 
The Effect of CNP overexpression on impaired endochondral bone growth of lbab/lbab mice 
In order to further characterize the impaired skeletal growth of lbab/lbab mice, we analyzed how their 
impaired endochondral bone growth recovered in response to targeted overexpression of CNP in the 
cartilage in vivo [12]. We crossed lbab/lbab mice with cartilage-specific CNP transgenic mice under 
the control of type II collagen promoter (CNP-Tg mice), and obtained lbab/lbab mice with transgenic 
expression of CNP in cartilage (lbab/lbabCNP-Tg mice) [12]. At the first week after birth, the 
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nasoanal length of lbab/lbabCNP-Tg mice was almost the same as that of lbab/lbab mice, and 
considerably smaller than that of wild-type mice: nasoanal lengths of wild-type, lbab/lbab, and 
lbab/lbabCNP-Tg mice were 4.38  0.06, 3.87  0.37, and 4.00  0.12 cm, respectively. 
Subsequently, lbab/lbabCNP-Tg mice began to grow larger than lbab/lbab mice, and promptly 
caught up with wild-type mice; although the nasoanal length of lbab/lbabCNP-Tg mice was still 
considerably smaller than that of wild-type mice until 3 weeks of age (5.70  0.57 and 6.71  0.10 cm, 
respectively, at the age of 3 weeks), it became almost comparable to that of wild-type mice after 
4-week-old (7.38  0.48 and 7.61  0.10 cm, respectively, at the age of 4 weeks). Further, the body 
weight of lbab/lbabCNP-Tg mice was almost the same as that of lbab/lbab mice and was smaller 
than that of wild-type mice until the age of 3 weeks, but was then promptly increased to a level 
comparable to that of wild-type mice (Supplemental Fig. 2). 
Soft X-ray analyses revealed that at the age of 2 weeks, the impaired growth of bones formed 
through endochondral ossification in lbab/lbab mice was partially recovered by targeted 
overexpression of CNP in cartilage in lbab/lbabCNP-Tg mice (Fig. 2a): the recoveries in the 
longitudinal length of cranium and the lengths of humerus, radius, ulna, femur, tibia, and vertebra, 
were 35, 73, 68, 37, 51, 63, and 27%, respectively (Fig. 2b). Furthermore, at the age of 10 weeks, the 
impaired endochondral bone growth in lbab/lbab mice was almost completely recovered by targeted 
overexpression of CNP in cartilage, as observed in lbab/lbabCNP-Tg mice (Fig. 2c, d). On the other 
hand, there were no significant differences in the width of cranium, which is formed via 
intramembranous ossification, among the three genotypes at either 2 or 10 weeks (Fig. 2b, d). 
Histological analysis showed that both the thickness of proliferative chondrocyte layer and 
that of hypertrophic chondrocyte layer, positive for immunohistochemical staining for type X collagen, 
were significantly decreased in lbab/lbab mice compared to those in wild-type mice at the age of 2 
weeks, as previously reported [12] (Fig. 3a, b). The thinner proliferative chondrocyte layer in 
lbab/lbab growth plate was completely recovered by targeted overexpression of CNP as observed in 
lbab/lbabCNP-Tg growth plate (Fig. 3c). The thinner hypertrophic chondrocyte layer in lbab/lbab 
growth plate was also considerably recovered in lbab/lbabCNP-Tg growth plate, although the extent 
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of the recovery was weaker than in the case of the proliferative chondrocyte layer (Fig. 3d). 
Immunohistochemical staining for PCNA revealed that the number of PCNA-positive cells is severely 
decreased in the proliferative chondrocyte layer of lbab/lbab growth plate (Fig. 3e). The number of 
PCNA-positive cells did not recover in the proliferative chondrocyte layer of lbab/lbabCNP-Tg 
growth plate, whereas the thinner proliferative chondrocyte layer in lbab/lbab growth plate was almost 
completely recovered in lbab/lbabCNP-Tg growth plate (Fig. 3c). The area positive for 
immunostaining of Ihh, one of markers of hypertrophic differentiation, was decreased in lbab/lbab 
growth plate compared to that in wild-type growth plate (Fig. 3f). The smaller size of the area positive 
for Ihh in lbab/lbab growth plate was almost completely recovered in lbab/lbabCNP-Tg growth plate 
(Fig. 3f). Immunohistochemical staining of MMP-13, a useful marker for the terminal hypertrophic 
chondrocytes, was not changed between three genotypes, indicating that the progression through the 
hypertrophy program was not accelerated in lbab/lbab growth plate (Fig. 3g). 
At the age of 10 weeks, the tibial growth plate of lbab/lbab mice continued to be thinner than 
that of wild-type mice, and was also completely recovered by overexpression of CNP in cartilage (Fig. 
4). 
 
Recovery of decreased bone volume in lbab/lbab mouse by CNP overexpression 
Three-dimensional CT analysis manifested a marked reduction in bone volume of the humerus in 
lbab/lbab mouse, and considerable recovery in lbab/lbabCNP-Tg mouse (Fig. 5). At the age of 10 
weeks, the quantified bone volume (BV/TV) and trabecular thickness (Tb. Th) of humerus in 
lbab/lbab mouse were 2.4% and 34.5 m, respectively, whereas those in wild-type mouse were 4.1% 
and 40.3 m, respectively. The decreased BV/TV and Tb. Th in lbab/lbab mouse were increased to 
5.4% and 37.0 m, respectively, in lbab/lbabCNP-Tg mouse. 
 
Organ culture experiments of tibiae from lbab/lbab mice 
In order to further analyze the impaired endochondral ossification of lbab/lbab mice, we preformed 
organ culture experiments using tibial explants from fetal mice (Fig. 6a) [15]. Because skeletal 
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phenotypes of mice heterozygous for the lbab allele were not different from those of wild-type mice, 
we compared the growth of tibial explants from lbab/lbab mice with that from lbab/+ mice. At the 
beginning of culture, both the total length and the sum length of cartilaginous primordia (CP) of 
lbab/lbab tibiae are significantly smaller than those of lbab/+ tibiae (3.80  0.04 vs. 4.25  0.03 mm 
and 2.19  0.02 vs. 2.43  0.01 mm, respectively, n = 812, each) (Fig. 6b, c). Tibial explants from 
lbab/lbab mice grew to the same extent as those from lbab/+ mice during a 4-day culture period; the 
difference in the total length or in the length of CP between lbab/lbab and lbab/+ explants at the end 
of culture was comparable to that at the beginning of culture (Fig. 6b, c). There was no significant 
difference in the length of the osteogenic center (OC) between two genotypes before and after the 
culture period (data not shown). 
 The treatment of CNP at the dose of 107 M stimulated the growth of both lbab/lbab and lbab/+ 
tibiae (Fig. 6b, c). CNP stimulated the growth of lbab/lbab tibiae more potently than that of lbab/+ 
tibiae; in the presence of 107 M CNP, the difference between the total length of lbab/+ tibiae and that 
of lbab/lbab tibiae was decreased (Fig. 6b), and furthermore, the CP length of lbab/lbab tibiae became 
almost the same as that of lbab/+ tibiae (Fig. 6c). The growth of OC was not stimulated by CNP in 
either lbab/lbab or lbab/+ explants (data not shown). 
 Histological examination at the end of culture period revealed that the length of the primordial 
growth plate (Fig. 7a), especially that of the hypertrophic chondrocyte layer positive for type X 
collagen immunostaining (Fig. 7b, c), was smaller in lbab/lbab explants than in lbab/+ explants. The 
area positive for immunostaining for Indian hedgehog (Ihh), one of markers for chondrogenic 
differentiation [16], tended to be a little decreased in lbab/lbab explants compared to that in lbab/+ 
explants, although the intensities of the immunostaining were not changed between two genotypes 
(Supplemental Fig. 3). Immunohistochemical detection of BrdU-incorporated chondrocytes revealed 
that BrdU-positive chondrocytes tended to be decreased in lbab/lbab explants compared to those in 
lbab/+ explants (Fig. 7d). Addition of CNP prominently increased the lengths of primordial growth 
plates (Fig. 7a) and their hypertrophic chondrocyte layers (Fig. 7b, c) of both lbab/+ and lbab/lbab 
explants. The lengths of primordial growth plate and its hypertrophic chondrocyte layer of lbab/lbab 
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explants treated with 107 M CNP became comparable to those of lbab/+ explants treated with the 
same dose of CNP (Fig. 7ac). CNP increased the areas positive for Ihh immunostaining both in 
lbab/+ and lbab/lbab explants. By addition of CNP, the sizes of the areas positive for, and the 
intensities of, Ihh immunostaining became not different between in lbab/+ and lbab/lbab explants 
(Supplemental Fig. 3). CNP did not increased BrdU-positive chondrocytes in lbab/lbab explants (Fig. 
7d). 
 Further we explored whether CNP controls the progression of growth plate chondrocytes 
through the different stages of maturation or not. Because the process of endochondral ossification 
occurs delayed in metatarsus compared to that in tibia in an individual, we performed organ culture of 
metatarsi as well as tibiae from fetal mice at 16.5 day post coitus, and examined the expression of type 
X collagen and Ihh. In case of lbab/+ organ culture, the area positive for immunostaining of type X 
collagen was reduced and that of Ihh was localized near the ossification center in metatarsal explants 
compared with those in tibial explants, indicating that metatarsal growth plate represents earlier stage 
of endochondral ossification than tibial growth plate (Fig. 8). The area positive for immunostaining of 
type X collagen was greatly reduced in lbab/lbab metatarsal explants compared with that in lbab/+ 
metatarsal explants, and recovered by addition of 10-7 M CNP to the same extent to that in lbab/+ 
metatarsal explants treated with vehicle. The area positive for immunostaining of Ihh became closer to 
ossification center in lbab/lbab metatarsal explants than in lbab/+ metatarsal explants, and was 




Previously we and other groups had reported in brief communications that the short stature phenotype 
of lbab/lbab mouse is caused by a mutation in the mouse CNP gene [11-13]. Here we further analyzed 
the skeletal phenotypes of lbab/lbab mouse, and reported the results in this full-length manuscript. 
Analysis of the growth curves of nasoanal and nasotail lengths revealed that the shortness of 
lbab/lbab mice is mild at birth, but rapidly progresses by the age of 3 weeks, and then after 
4-week-old, the ratio of the length of lbab/lbab mice compared to that of wild-type mice becomes 
almost constant. This suggests that CNP is especially crucial for the skeletal growth spurt that occurs 
in early life. Since CNP is expressed in the growth plate cartilage and works as an autocrine/paracrine 
regulator [5], CNP might affect the endochondral bone growth potently when the volume of growth 
plate cartilage is relatively abundant. 
We confirmed the thinness of the growth plate of lbab/lbab mice, especially in its 
hypertrophic chondrocyte layer, followed by the impaired growth of long bones. The thinness of the 
growth plate of lbab/lbab mice was almost completely recovered by targeted overexpression of CNP 
in the growth plate by the age of 2 weeks. On the other hand, the recovery of the shortness of the total 
length of lbab/lbab bones by CNP was only partial at 2-week-old, becoming complete at the age of 10 
weeks. This finding suggests that the recovery is evident earlier in the thickness of the growth plate 
than in the total bone length. In addition, immunohistochemistry for PCNA revealed that at the age of 
2 weeks, the proliferation of growth plate chondrocyte is decreased in lbab/lbab mice, and the 
decreased proliferation is not rescued by CNP overexpression, even though the thickness of the growth 
plate does fully recover. The reason why the decreased proliferation of chondrocytes in lbab/lbab 
growth plate was not rescued by CNP overexpression in chondrocytes is not clear, but it may because 
of the weak and slow expression of the CNP-transgene owing to the weak power of the promoter 
region. On the other hand, CNP could not increase the proliferation of growth plate chondrocytes in 
lbab/lbab explants in organ culture experiment in this study. The effect of CNP on chondrocyte 
proliferation might be so mild that other effects of CNP on growth plate chondrocytes, e.g., the 
stimulatory effect on matrix synthesis as we had previously reported [3, 4], for example, might 
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proceed ahead to recover the thinned growth plate of lbab/lbab mouse. The discrepancy between the 
effects on proliferation and matrix synthesis may explain in part the delayed recovery of bone length 
relative to growth plate thickness. On the other hand, immunohistochemical staining of type X 
collagen and Ihh in explanted growth plates at two different stages of endochondral ossification 
suggested that the progression of proliferative chondrocytes to hypertrophic chondrocytes was delayed 
in the lbab/lbab growth plate and recovered by addition of CNP. In addition to the result that the 
expressions of MMP-13 were not different between in the terminal hypertrophic chondrocytes of 
wild-type, lbab/lbab, and rescued growth plates, CNP might promote the hypertrophic differentiation 
of proliferative chondrocytes, but not accelerate the terminal differentiation of hypertrophic 
chondrocytes. 
In this study, we investigated the character of calcified bones of lbab/lbab mouse using 
three-dimensional CT analysis: the bone volume of lbab/lbab mouse was substantially decreased 
compared to that of wild-type mouse, and was recovered by cartilage-specific CNP overexpression. 
The mechanism of decrease in bone volume of lbab/lbab mouse is still unknown, but it would be 
postulated that CNP may be expressed in and affects on cells other than chondrocytes, i.e., osteoblasts 
or osteoclasts, in bone. Although overexpression of CNP was targeted to chondrocytes in our rescue 
experiments, early onset of the CNP-transgene expression from cartilaginous primordium might have 
been able to affect bone metabolism at the earlier stage of skeletogenesis [17], and may have 
continued to affect osteoblasts or osteoclasts near the growth plate cartilage in the later stage of 
skeletogenesis. Whereas several in vitro effects of CNP on osteoblastic cell lineages or osteoclasts are 
reported [18-28], in vivo effects of CNP on bone metabolism still remain elusive, and further 
experiments are now ongoing in our laboratory. 
We previously discovered that two strains of dwarf mice, cn/cn and slw/slw, are caused by 
spontaneous mutations in the GC-B gene [7, 8]. In humans, AMDM has been identified to be caused 
by spontaneous loss-of-function mutations in the GC-B gene [9, 29]. The lbab/lbab mouse, of which 
skeletal phenotype we have closely analyzed in the present paper, has a spontaneous loss-of-function 
mutation in the mouse CNP gene; by analogy to the GC-B gene, some forms of human skeletal 
dysplasias might be identified to be caused by mutations in the CNP gene in future. Thus far, no such 
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conditions have been discovered [30]. In the event such a discovery is made, the lbab/lbab mouse 
would then be a novel mouse model of a form of human skeletal dysplasias caused by a mutation in 
the CNP gene. 
In contrast to mice homozygous for the lbab allele, the growth and skeletal phenotype of 
mice heterozygous for the lbab allele were not different from those of wild-type mice, as is the case 
with heterozygous CNP knockout mice. This confirms that haploinsufficiency for the CNP gene does 
not exist in mice. Likewise heterozygotes for the GC-B knockout, the cn allele, or the slw allele 
exhibit no skeletal abnormalities [6-8]; thus, haploinsufficiency of the GC-B gene also does not exist 
in mice. Nevertheless, haploinsufficiency of the GC-B gene does exist in humans: heterozygous 
carriers of AMDM are reported to be shorter than expected for their population of origin [31]. The 
reason for the discrepancy is not clear at present, but may be due to differences between species or 
some other unknown mechanisms. We will have to perform further investigations on the skeletal 
phenotypes of the aforementioned lines of GC-B mutant mice; such experiments are now ongoing in 
our laboratory. 
In summary, in this study we more closely investigated the skeletal phenotypes of a novel 
CNP mutant mouse, lbab/lbab. The results of this study will be useful not only for further elucidation 
of the physiological role of CNP on endochondral bone growth, but also for the prediction of 
pathophysiology of a hypothetical chondrodysplasia caused by a mutation in the human CNP gene, 
which has not yet been discovered. 
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Fig. 1  
Growth and skeletal phenotype of lbab/+ and lbab/lbab mice. 
(a), (b) Nasoanal lengths (a) and body weights (b) of female wild-type (Wt, ), lbab/+ (), and 
lbab/lbab () mice (n = 28). (c) Whole skeletons of wild-type, lbab/+, and lbab/lbab mice at 2 
weeks of age. Wt, wild-type. Scale bar, 1 cm. (d) Histological analysis of the tibial growth plates of 
3-day-old mice. Arrows indicate hypertrophic chondrocyte layers. Alcian blue and hematoxylineosin 
staining. Scale bar, 100 µm 
 
Fig. 2 
The Effect of CNP overexpression on impaired endochondral bone growth of lbab/lbab mice. 
Whole skeletons (a, c) and bone lengths measured on soft X-ray films (b, d) of female wild-type (Wt), 
lbab/lbab, and lbab/lbabCNP-Tg mice at the age of 2 weeks (a, b) and 10 weeks (c, d). (a), (c) Scale 
bar, 1 cm, each. (b), (d) White bars, wild-type mice; black bars, lbab/lbab mice; gray bars, 
lbab/lbabCNP-Tg mice. CW, width of cranium; CL, longitudinal length of cranium; HL, humeral 
length; RL, radial length; UL, ulnar length; FL, femoral length; TL, tibial length; VL, vertebral length. 
n = 27 (b) and 35 (d) 
 
Fig. 3 
Histological analysis of tibial growth plates from 2-week-old wild-type (Wt), lbab/lbab, and 
lbab/lbabCNP-Tg mice.  
(a) Alcian blue and hematoxylineosin staining. Yellow bars (depicted as “P”) indicate proliferative 
chondrocyte layers, and red bars (depicted as “H”) indicate hypertrophic chondrocyte layers. (b) 
Immunohistochemical staining for type Ⅹ collagen. Scale bar in (a), (b), 100 µm, each. (c), (d) 
Heights of the proliferative (c) and hypertrophic (d) chondrocyte layers. n = 3, each. *, P < 0.05; **, P 
< 0.01. (e) The proportion of PCNA-positive chondrocytes in proliferative chondrocyte layers. n = 
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34. **, P < 0.01. (f), (g) Immunohistochemical staining of Ihh (f) and MMP-13 (g). Scale bar in (f), 
(g), 50 µm, each. 
 
Fig. 4 
Histological analysis of tibial growth plate from female 10-week-old wild-type (Wt), lbab/lbab, and 
lbab/lbabCNP-Tg mice.  
(a) Alcian blue and hematoxylineosin staining. Arrows indicate the width of growth plates. Scale bar, 
50 µm. (b) Total heights of the growth plates. n = 25, each 
 
Fig. 5 
Micro CT analysis of humeri from wild-type (Wt), lbab/lbab, and lbab/lbabCNP-Tg mice at the age 
of 10 weeks. Scale bar, 1 mm 
 
Fig. 6 
The effect of CNP on cultured tibiae from fetal lbab/+ or lbab/lbab mice.  
(a) A representative picture of a tibial explant from a fetal mouse. Total longitudinal length (Total) and 
the sum lengths of cartilaginous primordia (CP) are indicated. (b), (c) Graphs of Total (b) and CP  (c) 
lengths of cultured tibiae from lbab/+ and lbab/lbab mice treated with vehicle (veh.) or 107 M CNP 
(CNP) for 4 days. Circles indicate lbab/+ tibiae, and squares indicate lbab/lbab tibiae. At the end of 
culture, closed symbols indicate tibiae treated with vehicle, and open symbols indicate those treated 
with CNP. n = 812, each 
 
Fig. 7 
Histological analyses of the growth plates of tibial explants from fetal lbab/+ or lbab/lbab mice 
treated with vehicle (veh.) or 107 M CNP (CNP) for 4 days. 
(a), (b) Alcian blue and hematoxylineosin staining (a) and immunohistochemical staining for type Ⅹ 
collagen (b). Yellow bars in (a) indicate lengths of cartilaginous primordia and red bars in (b) indicate 
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heights of hypertrophic chondrocyte layers. Scale bar, 200 µm in each panel. (c), (d) Height of 
hypertrophic chondrocyte layer (c) and proportion of BrdU-positive cells (d) of the growth plate of 
tibial explant from fetal lbab/+ or lbab/lbab mice treated with 107 M CNP or vehicle at the end of the 
4-day culture period. n = 3, each. **, P < 0.01 in (c), and n = 23 each in (d). 
 
Fig. 8 
Immunohistochemical staining of type Ⅹ collagen (upper panels) and Ihh (lower panels) of the 
growth plates of metatarsal explants from fetal lbab/+ or lbab/lbab mice treated with vehicle (veh.) or 
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